CBP Sets June 15 Deadline for FDA Entries and Entry Summaries
As of June 15, ACE will be the only authorized system for filing electronic entries and entry summaries for certain Food and Drug Administration entries and entry summaries under certain entry types, said CBP in a Federal Register notice scheduled…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
for publication on Monday (here). On June 15, for entry types 01, 03, 06, 11, 23, 51 and 52, the Automated Commercial System “will no longer be a CBP-authorized [electronic system] for purposes of processing these electronic filings,” it said. “CBP will continue to monitor the FDA filing rates in ACE. Should there be a need to avoid a substantial adverse impact on trade, CBP will reassess the transition completion date for FDA filings,” said CBP. The Customs Commercial Operations Advisory Committee (COAC) recently joined industry calls for CBP to announce its ACE deadline for FDA entries, citing the trade industry’s need to know the date for development and training purposes.